Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
---|
02/16/2005 | EP1037906B1 Cyclopeptide derivatives with integrin inhibitor properties |
02/16/2005 | CN1582283A Benzothiepine ileal bile acid transport inhibitors |
02/16/2005 | CN1582280A 3, 4-di-substituted pyridazinediones as CXC chemokine receptor antagonists |
02/16/2005 | CN1582277A Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
02/16/2005 | CN1582274A Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
02/16/2005 | CN1582269A Hydroxyeicosenoic acid analogs |
02/16/2005 | CN1582168A Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |
02/16/2005 | CN1582151A Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibitory activity for the treatment hyperlipidaemia |
02/16/2005 | CN1582148A Derivatives of phenoxy-n-'4-(isothiazolidin-1, 1-dioxid-2yl)pheny!-valerian- acid amide and other compounds as inhibitors of the coagulation factor Xa in the treatment of thromboembolic diseases and tu |
02/16/2005 | CN1582147A Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
02/16/2005 | CN1580080A Heparin compound, and its preparing method and use |
02/16/2005 | CN1579520A Preparation for eliminating thrombus and promoting lactation, and its preparation method |
02/16/2005 | CN1579504A Effervescent tablets |
02/16/2005 | CN1579482A Blood-supplementing traditional Chinese medicine preparation and its production method |
02/16/2005 | CN1579435A Donky-hide blood-supplementing tonic and its preparation method |
02/16/2005 | CN1579417A Compound dewatered diuretic medicinal composition and its preparation method |
02/16/2005 | CN1579415A Yuzu Sea-cucumber osamine glycan injecta and its preparation method |
02/16/2005 | CN1579403A Composition for preventing fetus from nerviduct deformity and pregnant woman from ischemic anemia and preparation method thereof |
02/16/2005 | CN1579383A Troxerution guttate pill and preparation method thereof |
02/16/2005 | CN1189479C Use of leptin in inhibition of endothelial cell proliferation |
02/16/2005 | CN1189476C New thrombin inhibitors, their preparation and use |
02/16/2005 | CN1189209C Application of osteogenic growth peptide in promoting bematogenesis |
02/16/2005 | CN1189189C Medicine for eliminating thrombus and treating apoplexy |
02/16/2005 | CN1189182C Application of nano copper powder in preparation of antisenility medicine |
02/16/2005 | CN1189180C Bicarbonate dry powder composition for hemodialysis |
02/16/2005 | CN1189166C FC receptor modulators and uses thereof |
02/15/2005 | US6855833 Methods for producing amino substituted chromanes and intermediates thereof |
02/15/2005 | US6855830 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
02/15/2005 | US6855818 Vasodilation; heart imaging |
02/15/2005 | US6855806 Comprises secreted polypeptide for diagnosis and treatment of tumors, nervous system, reproductive and muscular disorder |
02/15/2005 | US6855803 Protein having hemolytic activity and gene encoding the protein |
02/15/2005 | US6855726 Heterocyclic amides such as 3-(1-5-((2R,6S)-2,6-dimethyltetra-hydro-1(2H)-pyridinyl)pentyl-2-oxo-1,2 -dihydro-3-quinolinyl) benzenecarboximidamide, administered as anticoagulants or for prophylaxis of cardiovascular disorders |
02/15/2005 | US6855722 Substituted indoles and their use as integrin antagonists |
02/15/2005 | US6855715 Drugs such as 1-(3-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4-(4-fluoro-2 -methylsulphonylphenyl)piperazine, used as anticoagulants |
02/15/2005 | US6855697 Troxerutin with a high content of trihydroxyethylrutoside and process for its preparation |
02/15/2005 | US6855532 Gene therapy; drug screening |
02/15/2005 | US6855512 Phenylacetic or heteroarylacetic acid derivatives; retinoid like activity |
02/15/2005 | US6855510 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
02/15/2005 | US6855102 Method for separating cells, especially platelets, and bag assembly therefor |
02/10/2005 | WO2005012309A1 Cyclic bioisosters of purine system derivatives and a pharmaceutical composition based thereon |
02/10/2005 | WO2005012272A1 Benzoxazepine compound |
02/10/2005 | WO2005012268A1 Sulfonamide derivative having isoxazole ring |
02/10/2005 | WO2005011724A1 A method of producing an anticoagulation effect |
02/10/2005 | WO2005011696A1 Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers |
02/10/2005 | WO2005011648A2 Use of cyclic bioisosteres of purine system derivatives for the treatment diseases caused by disorders of nitrergic and dopaminergic systems |
02/10/2005 | WO2005011645A2 Selected betaines and their uses |
02/10/2005 | WO2002064626A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
02/10/2005 | US20050033414 Drug-eluting stent with multi-layer coatings |
02/10/2005 | US20050033261 Drug/drug delivery systems for the prevention and treatment of vascular disease |
02/10/2005 | US20050033055 Edg receptor agonists |
02/10/2005 | US20050033049 Heterocyclic nitrogen compounds such as 1-(5-(5-Chlorothiophen -2-yl)-isoxazol-3-ylmethyl)-1H-indole-2-carboxylic acid (1-isopropyl-piperidin-4-yl)-amide, used as anticoagulants for prophylaxis of cardiovascular disorders |
02/10/2005 | US20050032851 E. g.,N-[[4-[2-(5-Methylpyridin-3-yl)-4-(trifluoromethyl)-1H-imidazol-1-yl]phenyl]sulfonyl]acetamide; side effect reduction; non-steroidal antiinflammatory agents; antiarthritic agents; analgesics; antipyretics; acylation of the corresponding sulfoamide by an anhydride a solvent and base |
02/10/2005 | US20050032830 Ether substituted imidazopyridines |
02/10/2005 | US20050032819 Quinazolinone derivative |
02/10/2005 | US20050032808 Pyrazine carboxamide compounds for use in treatment of obesity, psychiatric and neurological disorders; for example, N-(1-piperidinyl)-5,6-diphenyl-2-pyrazinecarboxamide |
02/10/2005 | US20050032799 Treating a CNS disorder by orally administering to a patient a therapeutically effective amount of lamotrigine or a pharmaceutically acceptable derivative; for treatment of epilepsy, pain, edema, multiple sclerosis, psychological disorders, schizophrenia, bipolar disorders; side effect reduction |
02/10/2005 | US20050032779 enzyme inhibitors such as 2-[4-(4-Dimethylaminophenyl)piperazin-1-yl]4,5-dihydroimidazo[4,5,1-ij]quinolin-6-one, used for treating or preventing disorders in which poly/ADP-ribose/ polymerase is involved |
02/10/2005 | US20050032693 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
02/10/2005 | US20050032690 Intravenous, subcutaneous, intradermal, or intramuscular administration; proteolysis |
02/10/2005 | US20050032681 Human antithrombin iiis and methods related thereto |
02/10/2005 | US20050032189 Novel protein derived from agkistrodon saxatilis emelianov and process preparing the same |
02/10/2005 | US20050032170 Expression vector comprising nucleotide sequences coding native sequence-4 (NS4) for use in identifying modulators for treatment and prevention of obesity, cachexia and anorexia |
02/10/2005 | US20050031607 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots |
02/10/2005 | US20050031603 Obtainable from whey fraction of milk curd; centrifugation; ultrafiltration; lyophilization |
02/10/2005 | US20050031577 Therapeutic polyesters and polyamides |
02/10/2005 | US20050031523 titrating an aqueous slurry of sodium zirconium carbonate to a pH of 3.5 to about 4.0 with a acidic agent,and washing the zirconium basic carbonate with water; renal dialysis applications and chemical intermediates |
02/10/2005 | CA2575760A1 Selected betaines and their uses |
02/10/2005 | CA2534464A1 Benzoxazepine compound |
02/10/2005 | CA2533687A1 A method of producing an anticoagulation effect |
02/09/2005 | EP1505063A1 Benzimidazole derivatives |
02/09/2005 | EP1505062A1 Heterocyclic derivatives and their use as antithrombotic agents |
02/09/2005 | EP1504761A1 Difructose anhydride-containing composition and use thereof |
02/09/2005 | EP1504027A2 Adipocyte complement related protein zacrp8 |
02/09/2005 | EP1503800A1 Treatment and prevention of tissue damage |
02/09/2005 | EP1503798A1 Stabilised solid compositions of modified factor vii |
02/09/2005 | EP1503785A2 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
02/09/2005 | EP1503783A1 A combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes |
02/09/2005 | EP1503782A1 A combination product comprising melagatran and an anti-arrhythmic oxabispidenes |
02/09/2005 | EP1503779A2 Methods for slowing senescence and treating and preventing diseases associated with senescence |
02/09/2005 | EP1503773A1 Hepatoprotective activity of 2 -p-hydroxybenzoylmussaenosidic acid |
02/09/2005 | EP1503761A1 Substituted piperazines as melanocortin receptor ligands |
02/09/2005 | EP1503753A2 A method for inhibiting platelet aggregation |
02/09/2005 | EP1503740A1 Monocompartment osmotic controlled drug delivery system |
02/09/2005 | EP1436252A4 Hydroxyfattysulfonic acid analogs |
02/09/2005 | EP1423132A4 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
02/09/2005 | EP1339717B1 Novel carbamate-substituted pyrazolopyridine derivatives |
02/09/2005 | EP1280805B1 Novel imidazotriazinones and the use thereof |
02/09/2005 | EP1244640B1 Oxazolidinone derivatives |
02/09/2005 | EP1079813B1 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
02/09/2005 | EP1037659A4 Fibrinolytic inhibitor for sealant |
02/09/2005 | EP0934310B1 Thio acid derived monocyclic n-heterocyclics as anticoagulants |
02/09/2005 | EP0365597B2 Improved processes for the treatment of vascular disease |
02/09/2005 | CN1578779A Small organic molecule regulators of cell proliferation |
02/09/2005 | CN1578767A Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
02/09/2005 | CN1578672A Rsv基因表达疫苗 Rsv gene expression vaccine |
02/09/2005 | CN1578661A Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
02/09/2005 | CN1578660A Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
02/09/2005 | CN1575821A Hemostatic devices and methods of making same |
02/09/2005 | CN1575796A Ligustrazine phosphate dripping pill and preparation thereof |
02/09/2005 | CN1188516C Coded nucleotide sequence of recombinant nattokinase and process for producing the same nattokinase |